ArticleNature cardiovascular research2024

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy.

James J Hartman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.